• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Study: Smartphone Therapeutic Helps Improve Fibromyalgia in Patients

    Sightpath Medical Acquires Accusite Surgical

    Sissel Lønning Andresen Named LINK Medical CEO

    CARMAT Resumes Commercial Artificial Heart Implants

    Junkosha Plans New Facility in Kasama, Japan
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Providence Enterprise USA Inc.

    Forefront Medical Technology
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Providence Enterprise USA Inc.

    Forefront Medical Technology
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Medtronic Drug-Coated Balloon Demonstrates Consistent Results in Two New Analyses

    The IN.PACT Admiral device demonstrated comparable clinically driven target lesion revascularization rates.

    Related Content
    • Shockwave Medical Appoints President and CEO
    • FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers
    • Medtronic Launches Resolute Onyx Drug-Eluting Stent in U.S.
    • Medtronic Launches Advanced StealthStation for Neurosurgery
    • FDA Designates Medtronic Action as Class I Recall
    Medtronic plc05.04.17
    Medtronic plc reinforced consistent results for its IN.PACT Admiral drug-coated balloon (DCB) with two new sub-analyses from the IN.PACT Global Study in patients with peripheral artery disease (PAD). The new data were reported at the annual 2017 Charing Cross Symposium (CX) in London, one of the world's largest educational meetings specializing in vascular and endovascular disease management.
     
    Sub-Analysis in Patients with Complex Lesions
    In a "Podium First" presentation at the conference, Gary Ansel, M.D., system medical director for Vascular Services at OhioHealth Riverside Methodist Hospital in Columbus, Ohio, presented one-year results analyzing outcomes in patients from the IN.PACT Global Study with complex lesions. The analysis compared standard usage patients (n=281) who met similar inclusion criteria for the IN.PACT SFA pivotal trial,1 an investigational device exemption (IDE) study, compared with use in a broader spectrum of patients (n=1125) who had wider inclusion criteria reflecting more real-world patients.2
     
    Results in both groups demonstrated consistent and positive outcomes with IN.PACT Admiral at one year. In the standard IN.PACT Global Study group, clinically-driven target lesion revascularization (CD-TLR) was 3.4 percent, which was comparable to 2.4 percent in a similar population in the IN.PACT SFA pivotal trial. CD-TLR for the group with complex lesions was 8.5 percent, despite the disease complexity observed in these patient types. These results were also consistent with the full clinical cohort for the IN.PACT Global Study (n=1406), in which one-year CD-TLR was 7.5 percent.
     
    Results of the primary safety endpoint were generally consistent across the cohorts and no safety signals were observed.
     
    "These sub-analyses show that IN.PACT Admiral continues to deliver durable and consistent results across our more typically treated patient populations," said Ansel. "Notably, the data in this study highlight that the IN.PACT Admiral DCB can be safe and effective when used in our patients with complex PAD, such as those with challenging calcified lesions and with significant co-morbidities."
     
    Sub-Analysis of Patients with Calcified Lesions
    Additionally, Fabrizio Fanelli, M.D., EBIR, professor of radiology at the Sapienza University in Rome, Italy, shared results of a new subset analysis of patients with complex, calcified lesions from the long lesion and chronic total occlusion (CTO) imaging cohort of the IN.PACT Global Study.
     
    The analysis included long lesion and CTO patients defined as having moderately severe or severely calcified lesions (n=72).3 Calcium levels were assessed by the site according to protocol and confirmed by core laboratory assessment. At one year, patients achieved primary patency rates of 88.8 percent as calculated by Kaplan-Meier analysis. Primary patency is the ability for the treated artery to remain open over time. The analysis also demonstrated a CD-TLR rate of 8.5 percent. Consistent with other data sets, no safety signals were observed. In 51.4 percent of subjects, provisional stenting occurred.
     
    Calcium remains a challenge within endovascular procedures and has historically been linked to higher provisional stenting rates, greater complications and poor outcomes. Directional atherectomy and specialty balloons, while not evaluated in this study, are commonly used to debulk or predictably dilate calcified lesions, which may minimize the need for provisional stents.4
     
    "Through our investments in the IN.PACT clinical program and ongoing studies, Medtronic is committed to partnering with clinicians to develop evidence-based treatments for complex PAD," said Mark Pacyna, general manager of the Peripheral business, which is part of Medtronic's Aortic & Peripheral Vascular division. "The adoption of IN.PACT Admiral as a frontline treatment option has been driven by its unparalleled clinical profile, which continues to demonstrate durability, safety, and efficacy across PAD patient populations."
     
    In collaboration with leading clinicians, researchers, and scientists worldwide, Medtronic offers a range of technology for the interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias.
     
    The IN.PACT Admiral drug-coated balloon is a clinically-proven, cost-effective primary endovascular therapy that enables physicians to treat claudication and restenosis for patients with femoropopliteal disease. It has been studied in 21 individual clinical trials demonstrating durable safety and clinical benefits. To date, more than 200,000 patients have been treated with the IN.PACT Admiral DCB.
     
    Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies. The company employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries.

    References:
    1. Patients with single lesions less than or equal to 18 cms, total occlusions less than or equal to 10 cms, no in-stent restenosis (ISR), and none to mild calcification.
    2. Patients with bilateral/multiple lesions, and moderate-to-severe calcification.
    3. Dattilo, R; J Invasive Cardiol 2014;26(8):355360.
    4. McKinsey, J. F., et al. (2014). JACC Cardiovasc Interv 7(8): 923-933.
    Related Searches
    • safety
    • assessment
    • cardiovascular
    • imaging
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Shockwave Medical Appoints President and CEO Shockwave Medical Appoints President and CEO
    FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers
    Medtronic Launches Resolute Onyx Drug-Eluting Stent in U.S. Medtronic Launches Resolute Onyx Drug-Eluting Stent in U.S.
    Medtronic Launches Advanced StealthStation for Neurosurgery Medtronic Launches Advanced StealthStation for Neurosurgery
    FDA Designates Medtronic Action as Class I Recall FDA Designates Medtronic Action as Class I Recall
    Medtronic Divests Technology to Cardinal Health for $6.1 Billion Medtronic Divests Technology to Cardinal Health for $6.1 Billion
    Medtronic Syncs Garmin Tracker Data into Patient Monitoring Platform Medtronic Syncs Garmin Tracker Data into Patient Monitoring Platform
    Personalized 3D Brain Maps to Guide Neurosurgeries Personalized 3D Brain Maps to Guide Neurosurgeries
    Medtronic Recalls StrataMR Adjustable Valves and Shunts Medtronic Recalls StrataMR Adjustable Valves and Shunts
    Closing the Loop on Diabetes Care Closing the Loop on Diabetes Care
    GORE TIGRIS Vascular Stent Gains Health Canada Approval for Treatment of PAD GORE TIGRIS Vascular Stent Gains Health Canada Approval for Treatment of PAD
    Balloon Technology Study Launched for Treatment of Below-The-Knee PAD Balloon Technology Study Launched for Treatment of Below-The-Knee PAD
    Medtronic Gains Health Canada Licence for Drug-Coated Balloon Medtronic Gains Health Canada Licence for Drug-Coated Balloon
     PQ Bypass Announces Positive Results From DETOUR I Study PQ Bypass Announces Positive Results From DETOUR I Study

    Related Breaking News

    • Cardiovascular
      Shockwave Medical Appoints President and CEO

      Shockwave Medical Appoints President and CEO

      Doug Godshall was most recently the CEO and a director of HeartWare International Inc.
      Business Wire 05.12.17

    • Cardiovascular
      FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers

      FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers

      Portfolio of heart failure devices offers effective pacing and access to the most advanced diagnostic imaging procedures.
      Medtronic plc 05.11.17

    • Cardiovascular
      Medtronic Launches Resolute Onyx Drug-Eluting Stent in U.S.

      Medtronic Launches Resolute Onyx Drug-Eluting Stent in U.S.

      FDA-approved device becomes first drug-eluting stent available in 4.5- and 5.0-mm sizes.
      Medtronic plc 05.01.17


    • Neurological | Surgical
      Medtronic Launches Advanced StealthStation for Neurosurgery

      Medtronic Launches Advanced StealthStation for Neurosurgery

      New platform to offer flexibility, ease of use, improved registration, and advanced visualization for custom workflows.
      Medtronic plc 04.24.17

    • FDA Designates Medtronic Action as Class I Recall

      FDA Designates Medtronic Action as Class I Recall

      Company had initiated voluntary field action related to its HVAD System Controllers and DC Adapters.
      Medtronic plc 04.19.17

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • Medtronic's Recall Of Mahurkar Catheters Is Class I
    • Cirtec Medical Corporation Acquires Precision Components Business From QMD
    • Environmental Sustainability Becoming Increasingly Important To Medtech Industry
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    Breaking News
    • Study: Smartphone Therapeutic Helps Improve Fibromyalgia in Patients
    • Sightpath Medical Acquires Accusite Surgical
    • Sissel Lønning Andresen Named LINK Medical CEO
    • CARMAT Resumes Commercial Artificial Heart Implants
    • Junkosha Plans New Facility in Kasama, Japan
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Coatings World

    Latest Breaking News From Coatings World

    ROSS Offers Heavy-Duty Three Roll Mills for High Viscosity Dispersions
    PPG Achieves ISO 14001 Certification of Environmental Management System
    AmCoat’s Rhino Shield and Floor Shield Break Records in 2022
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Study: Smartphone Therapeutic Helps Improve Fibromyalgia in Patients
    Sightpath Medical Acquires Accusite Surgical
    Sissel Lønning Andresen Named LINK Medical CEO
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Merck Revenues Up 22% for the Year to $59.3B
    BioNTech SE Completes Proprietary Plasmid DNA Manufacturing Facility in Marburg, Germany
    Dragonfly Therapeutics Appoints Joseph Eid as President of Research & Development
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    e.l.f. Beauty Net Sales Grow 49% in Third Quarter of 2023
    DOVE Introduces ‘Next-Gen’ Body Wash in Sleek New Sustainable Bottle
    Ariana Grande Agrees to Purchase Assets Tied to r.e.m. beauty from Forma Brands
    Happi

    Latest Breaking News From Happi

    CVS Introduces New Beauty, Personal Care Brand One+Other
    Sharon Personal Care Expands Green Product Portfolio and Formulation Capabilities
    Ecolab Enters Consumer Retail with New Ecolab Scientific Clean Brand at Home Depot
    Ink World

    Latest Breaking News From Ink World

    International Paper Named to Fortune's List of World's Most Admired Companies
    Flint Group Launches Sustainable UV LED Dual Cure Ink
    Smurfit Kappa's Sustainable Solutions Take Home Eight WorldStar Awards
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Brook + Whittle acquires LLT Labels
    ABG adds laser perforation to shrink sleeve seaming solution
    PPC Flexible Packaging acquires Israel-based StePac, MAPfresh Holdings
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Qvin Menstrual Blood Diagnostic Device Receives FDA Approval in Thailand
    Andritz, KCF Technologies Form Agreement
    Freudenberg e-Power Systems, LG Energy Solution Announce Partnership
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Adrian Tyndall Joins Axogen's Board of Directors
    ADSM-Synchro Medical Acquired by Tyber Medical
    Solid Growth Ahead for Orthopedic Power Tools Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Infineon Concludes Very Profitable 1Q 2023
    LOPEC 2023: Here are the Highlights for Printed Electronics
    Employee-Led Giving at ORNL Provides $937,000 to Area Nonprofits in 2022

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login